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The Herpesviridae Family 
The herpesviruses represent a large, clearly defined group of viruses. 
They are responsible for a variety of human and animal diseases, and 
nearly 100 herpesviruses have been characterized to date (Fields et al., 
1990). Herpesviruses have been isolated from man, most domestic animals, 
wild mammals, birds and fish (Stranberg et al., 1965; Fabricant et al., 1974; 
Wolf et al., 1971). The herpesviridae family is divided into three 
subfamilies, a-herpesvirinae, ~-herpesvirinae, and y-herpesvirinae. This 
classification is based on thier biological properties and genomic structure 
(Roizman et al., 1982). 
The a-herpesviruses characteristically have a short replication cycle, 
are highly cytopathic, and establish latent infections in nerve cells, 
particularly neurons in the trigeminal ganglia (Roizman et al., 1982; 
Baringer, 1976). Human herpes simplex virus (HSV) type 1 and type 2, 
varicella zoster virus, simian agent 8, B virus, pseudorabies virus and 
equine herpesvirus (EHV) types 1, 3 and 4 are all examples of a-
herpesviruses. In the bovine species, bovine herpesvirus-! (BHV-1), bovine 
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herpes mammillitis virus (BHV-2), BHV-5 and BHV-6 (Roizman, 1982; 
Plummer et al., 1969 and 1973; Mortin et al., 1966) are members of the a-
herpesvirus subgroup. 
The ~-herpesviruses are the cytomegaloviruses (CMV). They are 
characterized by a relatively long replication cycle, their species-specificity, 
and establishment of latent infections in the salivary glands, kidneys and 
lympho-reticular tissues (Plummer et al., 1969; Wittmann, 1989). The ~­
herpesviruses include human CMV, EHV-2 and BHV-4 (Roizman et al., 
1982; Wittmann, 1989). 
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The y-herpesviruses include human Epstein-Barr virus, BHV-3, and 
gallid herpesvirus-2 (Churchill et al., 1967). The y-herpesviruses commonly 
cause oncogenic transformation ofT- and B-lymphocytes and establish 
latent infections in the lymphoid tissues (Wittmann, 1989). 
Bovine Herpesvirus Type 1 (BHV -1) 
General Virion Structure 
The bovine herpesviruses are largely comparable to other members of 
the herpesvirus family (Roizman, 1978). BHV-1 consists of an icosahedral 
nucleocapsid with a diameter 95-110 nm which is made up of 162 
capsomeres. The capsid encloses the viral DNA genome which has a total 
length of approximately 137 kilo base pairs (kbp) (Mayfield et al., 1983). 
The nucleocapsid is surrounded by an electron-dense material called the 
tegument which in turn is surrounded by a lipid bilayer envelope, forming a 
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pleomorphic virion 150-200 nm in diameter (Valicek et al., 1976; Wittmann, 
1989). The tegument is probably involved in maintaining the shape and 
structure of the virion (Fong et al., 1973). The envelope, derived from the 
host cell membrane, has several viral glycoproteins anchored in it (Epstein, 
1962). These surface glycoproteins appear as spikes by electron microscopy 
(Linda, 1986). 
Classification of BHV -1 into Subtypes 
BHV-1 isolates or strains have been subdivided into 3 subtypes: BHV-
1.1, BHV-1.2, and BHV-1.3 (Metzler et al., 1985; Metzler et al., 1986; Friedli 
et al., 1987; Wittmann, 1989). These subdivisions are based on restriction 
endonuclease (RE) cleavage pattern of the viral genome, viral protein 
profiles, and reactivity of the virus with monoclonal antibodies. To date, 
most BHV-1 isolates can be assigned to one of these three subtypes. 
Subtype 1, which the Cooper strain typifies, are commonly associated with 
infectious bovine rhinotracheitis (IBR). Subtype 2 of which strain K22 is 
the protype are associated with infectious pustular vulvovaginitis (IPV). 
Subtype 3 strains are few and are associated with encephalitis. Subtype 2 
can be further subdivided into types 2a and 2b by differences in their viral 
polypeptides. Subtype 3 can also be further subdivided in types 3a and 3b, 
represented by the N-569 and A-663 strains respectively (Metzler et al., 
1987). Subtype 3, also known as bovine encephalitis virus (Studdert, 1989), 
is responsible for outbreaks of neurological disease in calves. These 
outbreaks have been recorded in Australia and Argentina (French, 1962., 
Carrillo et al., 1983; Metzler et al., 1986). Although outbreaks of fatal 
encephalitis caused by BHV-1 have been recorded in the United States 
(Barenfus, 1963., Eugester et al., 1974) the virus isolated from such 
outbreaks were only identified by serology as BHV-1 virus. 
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Significant differences have been observed between the genomes of 
the different BHV-1 subtypes. TheRE migration pattern ofBHV-1.1 and 
BHV-1.2 strains are different, but oruy slightly (Engels et al., 1981). The 
RE enzyme Hpa I produces two distinctly different cleavage patterns 
(Gregerson et al., 1984). Whereas the BstE II REmigration pattern of 
BHV-1.1 and BHV-1.2 are very similar with only sight differences in the 
mobility of the G fragment, the BHV-1.3 BstE II migration pattern is very 
different. BstE II also distinguishes BHV-1.3a and BHV-1.3b (Engels et al., 
1986/87). The differences between BHV-1.1 and BHV-1.2 are restricted to 
the regions of the genome corresponding to map units 0.09-0.2 and 0.83-
0.92, whereas differences in BHV-1.1 and BHV-1.3 are distributed 
throughout the genome (Engels et al, 1986/87). There is 95% homology 
between BHV-1.1 and BHV-1.2 strain genomes by DNA/DNA hybridization, 
whereas the similarity between the genomes ofBHV-1.1 and BHV-1.3 is 
only 85% (Engels et al., 1986/87). 
Bagust (1972) compared four different BHV-1 strains serologically 
and reported that the antigenic nature of N-569 BHV-1.3 was significantly 
different from the three other isolates by kinetic neutralization test. 
Separation of BHV -1.1 and BHV -1.2 by virus neutralization (VN) tests using 
rabbit hyperimmune sera was not possible (Bowling et al., 1969), although 
slight antigenic variation could be observed by using neutralizing kinetic 
assays (Bagust, 1972; House et al., 1972). 
Viral Polypeptides and Glycoproteins 
BHV-1 has at least 33 structural (virion) polypeptides, and of these, 
11 are glycoproteins (Misra et al., 1981 ). These viral polypeptides can be 
divided into alpha (immediate early), beta (early), and gamma (late) 
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proteins on the basis of order of appearance in the infected cells. The 
glycoproteins gl, gil and gill are the major BHV-1 glycoproteins involved in 
virus neutralization; gl and gil are beta proteins and gill is a gamma 
protein. Glycoproteins gl, gil and giV were found to induce high levels of 
antibodies in cattle, which could neutralize virus and participate in antibody 
dependant cellular cytotoxicity (ADCC) (Babiuk et al., 1987). 
The nomenclature for the BHV-1 viral glycoproteins was suggested by 
van Drunen Littel van den Hurk and Babiuk (1986). Four unique 
glycoproteins or glycoprotein complexes were recognized by a panel of 
monoclonal antibodies to BHV-1. Glycoprotein gl corresponds to the 
glycosylated viral polypeptides (GVP) 6/11a/16K (130,000 mol. wt. 
glycoprotein), and gil and gill to GVP 7 and GVP 9, respectively. There is 
also a giV which corresponds to the GVP 11b protein. Bolton et al., (1983) 
found that the gp9 and gp11 described by Misra et al., (1982) corresponded 
to their GVP 8 and GVP 13, and constituted the major surface antigen 
which comprised the envelope of BHV-1. 
The beta proteins are more immunogenic than the gamma proteins 
--- --- ------
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(Ludwig et al., 1987). Glycoprotein gi is an external surface (beta) protein 
of infected cells and participates in virus neutralization and complement 
mediated immunocytolysis of infected cells (Misra et al., 1982) Sodium 
dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) analysis of 
BHV-1 infected cells revealed two major immunogenic glycoproteins, GVP 
93 (giii) and GVP 7 4 (gii) which induced neutralization antibodies 
(Gregerson et al., 1985). giii induced both neutralizing and 
hemagglutination inhibiting antibodies (Trudel et al., 1987). Using 
monoclonal antibodies to different antigenic sites on BHV-1 glycoproteins, it 
was found that some antigenic glycoproteins mediate virus neutralization 
both with and without complement (Okazaki et al., 1986). Using 
monospecific sera and monoclonal antibodies, major BHV-1 glycoproteins 
involved in viral neutralization were 180/97K, (giii) 150/77K (giV) and to 
lesser extent 130/74/55K (gi) (Marshall et al., 1986). 
Herpesvirus attachment and penetration are mediated by 
glycoproteins (Liang et al., 1991). Penetration occurs by fusion of the viral 
envelope with that of the host cell plasma membrane (Wudunn and Spear, 
1989). After penetration, the nucleocapsid is transported to the cytoplasm 
and viral DNA is released into the nucleus, where virus replication occurs. 
Newly assembled nucleocapsids acquire their envelope from the inner 
lamella of the nuclear membrane, from the cytoplasmic membrane, or from 
the plasma membrane (Fong et al., 1973). Mature virions accumulate in the 
membrane systems of the host cell and may be released slowly by vacuolar 
membrane fusion and exocytosis, or by the lysis of the infected cells 
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(Wittmann, 1989; Gibbs et al., 1977). 
Cell to cell spread ofBHV-1 may be facilitated by gill (Okazaki et al., 
1987). Tunicamycin blocks transport of glycoproteins gland giii to the cell 
surface and inhibits production of infectious particles (van Drunen Littel 
van dan Hurk et al., 1985). Liang et al., (1991), using a BHV-1 gill gene-
deleted mutant, demonstrated that gill function is not required for growth 
of virus in cell culture. However, some impaired functions were noted such 
as defective attachment, delay in replication and lower titer of extracellular 
viruses; giii appeared to be the major glycoprotein involved in cell 
attachment, although gl and giV also contributed to some extent. 
Clinical Disease in Cattle 
BHV-1 is a major viral path<;>gen of cattle. It can cause several 
clinical entities which include IBR, IPV and meningoencephalitis. 
Infectious Bovine Rhinotracheitis. IBR was first described as a new 
respiratory tract disease of feedlot cattle in the US in 1955 (Miller, 1955 ). 
According to McKercher et al., (1950) the disease was. first observed in a 
feedlot in Colorado in 1950. The virus was isolated soon thereafter (Madin, 
1956). It was recognized in dairy cattle in California in 1953 and Schroeder 
et al., (1954) reproduced the disease in experimental cattle and suggested 
that the disease may be caused by some virus. IBR virus has also been 
isolated from cattle affected with conjunctivitis (Abinanti and Plummer, 
1961) and from the uterine exudate of cows showing fever and metritis with 
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mucopurulent discharge (Lomba et al., 1976). Metritis may also occur as a 
result of artificial insemination with semen contaminated with BHV-1 
(Kendrick and McEntee, 1965; Karhs, 1977). BHV-1 has also been 
associated with alimentary tract infection and has been isolated from calf 
feces without any diarrhea (Baker et al., 1960). More frequently, diarrhea 
is a clinical sign of the generalized and often fatal BHV -1.1 virus infection 
of young calves (Curtis et al., 1966). BHV-1.1 has also been associated with 
and isolated from cases of mastitis (Gibbs et al., 1977). Abortion is also 
characteristic of BHV -1.1 infection, and modified live IBR vaccine has 
caused abortion in cows (McKercher, 1964). Kendrick (1965) demonstrated 
experimentally that IBR virus causes abortion. 
Infectious Pustular Vulvovaginitis. IPV was first described as a 
venereal disease by a Swiss veterinarian in the year 1841 (Wittmann, 1989). 
This disease was noticed in heifers, dairy cows and bulls (Kendrick, 1958). 
The infection arises invariably from the introduction of virus to the mucosa 
of the genital tract by coitus or via external agents rather than from a 
viremic phase associated with BHV-1lesions elsewhere in the body (Gibbs 
et al., 1977). The mucosal surface of the genital tract does not need to be 
abraded for infection to become established (Collings et al., 1972). The 
BHV-1.2 virus does not interfere with fertility (Saxegaad, 1970) and does 
not cause abortion (Gibbs et al., 1977). 
------- --
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Meningoencephalitis. Occasionally, BHV-1 causes neurological 
disease in young calves between the ages of 3-10 months. This is 
characterized by incoordination, muscular tremor, recumbency, aimless 
circling, ataxia, blindness and eventually death (Eugester et al., 1974; 
French, 1962; Carrillo et al., 1983). Outbreaks of the BHV-1 encephalitis 
seem to be more prevalent in Australia and Argentina than elsewhere in the 
world. Recently it was also observed in Brazil (Weiblen et al., 1989). In the 
USA, an outbreak of BHV-1 encephalitis was first reported in dairy calves 
in Los Angeles, California (Barenfus et al., 1963). Another outbreak was 
reported from Texas in 1974 in range calves (Eugester et al., 1974). 
The first case ofBHV-1 encephalitis to be reported was in Australia 
in 1959-61 (Johnston et al., 1962). The virus isolate from that outbreak 
was designated as N-569 (French, 1962). This encephalitic strain was 
shown to produce encephalitis in experimental calves inoculated 
intranasally or intravaginally (Bagust et al., 1972). Hallet al., (1966) 
reported that calves infected with N-569 developed encephalitis whereas 
standard respiratory and genital strains of BHV-1 inoculated in similar 
ways did not produce encephalitis. Bagust et al., (1972) indicated that N-
569 is antigenically different from BHV -1 IBR strain. Brake and Studdert 
(1985) studied the molecular epidemiology and pathogenesis of ruminant 
herpesviruses including buffalo, caprine and bovine encephalitis 
herpesviruses. They reported that three epidemiologically unrelated 
encephaiopathic bovine herpesviruses had similar restriction enzyme 
fingerprints that were totally different from BHV-1.1 and BHV-1.2 and 
other ruminant herpesviruses. They proposed bovine encephalitis 
herpesvirus as the prototype of a new bovine herpesvirus type. 
Latent Infection in Cattle 
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All herpesviruses are capable of establishing latent infection in their 
host as a sequel to primary infection (Gibbs et al., 1977). After 
multiplication at the local site of infection, BHV-1 enters the peripheral 
nervous system and is transported presumably by centripetal spread via 
neurons, mainly to the trigeminal and sacral ganglia (Narita et al., 1981). 
After invading nerve fibers or ganglia, BHV-1 is no longer accessible to 
humoral antibodies (Narita et al., 1980). Virus residing in trigeminal 
ganglia are responsible for recurrent infections (Baringer, 1976). After 
treatment with dexamethasone (DM),_BHV-1 is reactivated and travels 
centrifugally through the nerve fiber to mucous membranes where they 
replicate. When cattle, that had been previously exposed experimentally to 
BHV-1 and recovered, were inoculated intravenously with DM daily over a 
period of several days, virus was excreted in nearly all animals examined 
(Davies and Carmichael, 1973). Reactivation of BHV-1 resulted in an 
anamnestic IgG response and a secondary IgM antibody response. 
Reactivation of latently infected BHV-1 stimulated the formation of 
antiviral antibody of the IgG 1 and IgG2 classes, which can distinguish this 
response from a primary infection in which IgG2 was not produced (Guy 
and Potgieter, 1985 ). 
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Immune Response of Cattle to BHV-1 Infection 
Following natural infection or vaccination with a modified live BHV-1 
vaccine, cattle develop both a humoral and a cell-mediated immune (CMI) 
response (Kahrs, 1977; Babiuk et al., 1974). 
Humoral Immune Response 
Systemic humoral immune responses depend on serum 
immunoglobulins (Rouse and Babiuk, 1978). The production of antibodies to 
BHV-1 in cattle begins at 8-12 days postinfection (PI), and may persist for 
66 months (Chow, 1972). IgM antibodies appear first, followed by IgG. 
During the first month, both classes require complement for neutralization, 
but IgG becomes complement-independent and predominates in anamnestic 
responses (Rossi and Kiessal, 1976). Guy and Potgieter (1985) reported that 
maximum IgM activity was detected on day 14 PI, whereas maximum IgG 
antibody titers were reached by day 35 PI. IgG declined more slowly after 
infection than IgM which declined rapidly. The presence of IgM indicates 
recent exposure to the virus (Guy and Potgieter, 1985). 
The role of antibodies in recovery from BHV -1 infection is 
questionable. Antibody appears very late in BHV-1 infection (Kahrs, 1977; 
Rouse and Babiuk, 1978). BHV-1, like other herpesviruses, escapes the 
immune system by spreading through intercellular bridges or through 
neural ganglia. However, antibodies are known to limit the spread of some 
other viruses, such as picornaviruses, which spread by the way of 
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extracellular route (Rouse and Babiuk, 1978). Antibodies cooperate, in vivo, 
with other components of the immune system; complement (antibody 
mediate complement lysis) (Rouse et al., 1975), leukocytes (ADCC) (Shore et 
al., 1974) or both (ADCC-C). Complement mediated destruction of antibody 
sensitized virus infected cells in vitro has been reported (Babiuk et al., 
1975). ADCC occurs when an effector cell, equipped with a receptor for the 
Fe portion of immunoglobuli:r;1 (IgG ), binds with the Fe portion of an 
antibody which in turn binds to viral antigens on the surface of a virus 
infected cells (Shore et al., 1974). The ADCC-C is effective in early recovery 
when IgM is predominant, levels of antibodies are low, and number of 
effector cells are low. 
Cell Mediated Immune Response 
Cell mediated immunity is thought to play a crucial role in resistance 
and recovery from BHV-1 infection (Davies and Carmichael, 1973; Rouse 
and Babiuk, 1974). Rouse and Babiuk (1974) observed a lymphocyte blast 
cell response soon after infection and the disappearance of virus from nasal 
secretions before the appearance of significant amounts of circulating 
antibodies. They used a blast cell assay to confirm their finding that 
peripheral blood lymphoctytes (PBL) were able to prevent viral plaque 
formation in the cell monolayer infected with BHV-1. The inhibition was 
shown to be immunologically specific and involved suppression of viral 
replication rather than destruction of virus infected cells. Two main factors 
essential for CMI are antigen recognition and effector or mediator function. 
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These functions are implemented by T-lymphocytes and phagocytes 
(macrophages) ( Tizard, 1987). T-lymphocytes produce mediator factors 
(lymphokines) which require reciprocal interaction with phagocytes (Rouse 
and Babiuk, 1978). The T-cells can be directly cytotoxic, activate 
macrophages and produce interferon (Rouse and Babiuk, 1978). 
Non-Specific Immunity 
Interferon (IFN) plays an important role in non-specific immunity 
and in protecting animals from BHV-1 infection. INF can be induced in 
cattle by infecting them intranasally or via the genital tract ( Babiuk et al., 
1985). Viral infection induced high levels of IFN locally, which is 
considered important in recovery from BHV-1 infection (Rouse and Babiuk, 
1978). d'Offay and Rosenquist (1988) reported that although BHV-1 virus 
induce IFN production in nasal secretions of calves, the amount of viral 
replication was not directly correlated with amount of IFN produced, nor 
did greater interferon production in animals result in less virus excretion. 
Natural killer (NK.) cells exhibit spontaneous cytotoxicity against 
neoplastic cells and viral infected cells ( Tizard, 1987). Following infection 
with BHV-1, a transient increase in NK-cell activity was observed (Babiuk 
et al., 1985). 
Quantitating Antibody Response in Cattle 
Several procedures have been used to quantitate antibodies in serum of 
cattle. These include the indirect fluorescence antibody test, indirect 
hemagglutination test, reverse passive hemagglutination, complement 
fixation test, enzyme linked immunosorbant assay (ELISA) and virus 
neutralization (VN) test (Engvall et al., 1972; Edward and Gitoa, 1987; 
Wardly and Crowther, 1982). 
Virus Neutralization Test 
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The detection of neutralizing antibodies in the serum of cattle is 
indicative of infection. The VN test is the only serological test that 
measures virus neutralizing antibodies (Carbery et al., 1972). Standards for 
virus growth rate, dose response curve, variation with and between tests, 
and relationship of amount of virus to serum titer were established by 
Mohanty and Lillie (1965). A standard serum neutralization test for BHV-1 
has been established by Carbary et al., (1972). The constant virus and 
varying serum dilution neutralization test was compared to the constant 
serum and varying virus. It was found that the constant serum and varying 
virus procedure was more sensitive, but with constant virus and varying 
serum dilution, accurate results were obtained when 50 to 100 TCID50 of 
virus were added to 2-fold serum dilutions (House and Baker, 1970). 
Although the VN test is accepted as the standard test for the serological 
diagnosis of the BHV-1 (Collins et al 1984; House and Baker, 1970), it is 
slow, expensive and takes days before the results can be read. 
Enzyme linked Immunosorbant Assay (ELISA) 
ELISA was first introduced by Engvall and Perlmann in 1972. They 
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used it for the quantification of specific antibodies by enzyme labelled 
antiglobulin. The technique is as sensitive as the radioimmunoassay. The 
ELISA has wide applications and has been used with protozoa, helminth, 
bacteria, mycoplasma, and to diagnose viral diseases both by detecting viral 
antigen or antibody immune response (Wardley and Crowther, 1982). 
Payment et al., (1979) used the ELISA technique to detect BHV-1 antibodies 
in sera. The detection of BHV -1 antigen was increased 50-fold by using 
biotin and avidin interaction to amplify the reaction (Edward and Gitao, 
1987). 
Experimental Inoculation of Rabbits with BHV-1 
Rabbits were found susceptible to BHV-1 and have been used as an 
experimental model for BHV-1 (Lupton et al., 1980). Neonatal rabbits may 
be useful to study the pathogenesis of BHV-1 infection (Kelly, 1977). In 
adult rabbits treated with DM, infection was exacerbated and resulted in 
systemic infection similar to neonatal infection (Lupton et al., 1974). 
Armstrong et al., (1961) produced a mild erythematous lesion in rabbits 
inoculated intradermally with BHV-1. Rabbits have also been used to study 
the neuropathogenicity of BHV-1 in our laboratory (d'Offay et al., 1990). 
When the Cooper and an encephalitic (EC) strains ofBHV-1 were inoculated 
on the scarified cornea of weanling rabbits, at least half of the rabbits 
inoculated with the EC strain developed fatal encephalitis between 12-14 
days PI, whereas rabbits inoculated ocularly with same dose of Cooper 
strain did not develop encephalitis (d'Offay et al., 1990). 
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Specific Objectives of this Study 
The first objective of the study was to determine the immune 
response of rabbits to infection with two stains of BHV-1, a respiratory 
(Cooper) strain and an encephalitic (EC) strain. These viruses were 
inoculated on the scarified cornea and sera were collected from infected 
rabbits sacrificed on various days PI. Rabbits were also inoculated with the 
viruses intranasally and sera collected on day 21 PI. Serum neutralizing 
antibodies were determined by the VN test, and the ELISA was used to 
determine serum antibodies that bound to viral antigen. 
The second objective of the study was to determine to what extent 
serum antibodies of infected rabbits recognized the two virus strains. VN 
tests were performed using each virus strains as test virus, and ELISA was 
carried out using both the EC and Cooper viruses as antigens. Also, viral 
proteins separated by SDS-PAGE, were transferred to nitrocellulose paper 
and sera were reacted to these by western blot to determine the viral 
polypeptides recognized by the serum antibodies. Furthermore, viral 
polypeptides and glycosylated viral polypeptides were radio-labelled 
metabolically, separated by SDS-PAGE and identified by autoradiography. 
The third objective was to identify determinants responsible for- the 
antigenic differences observed between the two strains. Hyperimmune sera 
and sera made to certain specific viral glycoproteins (gi and gill) were 
reacted to viral polypeptides by western blotting. 
CHAPTER II 
MATERIALS AND METHODS 
. Viruses and Cells 
Two strains ofBHV-1 were used in these studies: the Cooper strain 
(ATCC VR-864 strain; Colorado-!, Cooper-1) (York, 1957) and the EC strain 
(Eugester et al., 1974). The Madin Darby bovine kidney (MDBK) cell line 
was used for the propagation of viruses. MDBK cells were grown in Eagle 
minimal essential medium (MEM) supplemented with non-essential amino 
acids, L-glutamine (200 mM), antibiotics (penicillin, 100 units/ml; 
streptomycin, 100 ug/ml; fungizone, 0.25 ug), 25 mM HEPES buffer, 7.5% 
sodium bicarbonate and 5% fetal calf serum (FCS). 
Both strains were plaque purified three times before making the 
virus stock for inoculation purposes. For virus stock preparation, MDBK 
cells were infected at a multiplicity of infection of approximately 1. When 
cells exhibited 4+ cytopathic effect (CPE), monolayers were scraped and 
infected cells centrifuged at 1800 x gat 4°C for 10 minutes. Pellets were 
resuspended in MEM containing 5% FCS, freeze/thawed 3 times, 
centrifuged briefly, and the supernatant (virus stock) stored in individual 
vials at -70°C. Virus titration was done by plaque assay on MDBK cells. 
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The EC strain virus stock contained 2.0x108 PFU/ml and the Cooper virus 
stock 2.2x108 PFU/ml. 
Animal Inoculation 
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Weanling New Zealand White rabbits weighing 1-2 lbs were used for 
all studies. 
In the first study, two groups of rabbits (18/group) were inoculated 
ocularly on the scarified cornea with 107 PFU of the Cooper strain 
(Group 1) or with 107 PFU of the EC strain (Group 2). Blood was collected 
by cardiac puncture ( 2 rabbits/group) on days 1, 3, 5, 8, 11, and 14 PI. 
Sera were collected by centrifugation and stored at -70°C. 
In the second study, anaesthetized rabbits were inoculated with virus 
intranasally. Four rabbits were inoculated with 2x107 PFU of the EC 
strain virus and three with the same dose of the Cooper strain. One control 
rabbit was not inoculated. Blood was collected on day 21 PI from all 
surviving animals. 
Production of Hyperimmune Sera 
Two groups of rabbits were used for the production of hyperimmune 
sera using the EC and Cooper strains. The first group (n=2) was injected at 
10 day intervals intramuscularly with the EC strain mixed with incomplete 
Freund's adjuvant. The second group (n=4) were inoculated with Cooper (2) 
or EC (2) intradermally in the foot pad and after one month were inoculated 
every 2 weeks with virus mixed with incomplete Freund's adjuvant. One of 
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the rabbits inoculated with the Cooper strain died during the experiment. 
Blood were collected prior to each virus exposure and serum neutralizing 
antibodies were measured in the sera on each occasion. For the rabbit anti-
Cooper gland anti-Cooper gill sera, the glycoproteins were purified using 
preparative SDS-PAGE gels and SDS-hydroxylapatite column 
chromatography. After purification, glycoprotein was inoculated into 
rabbits as described (Eberle and Courtney, 1980). 
Serum Neutralization Test 
Neutralizing antibody titers in sera were determined by a microtiter 
serum neutralization test, using 96-well tissue culture plates (Falcon 
Labwear) as described by Carbery et al., (1972) with some modifications. 
All sera were heat inactivated at 56°C for 30 minutes before being tested. 
Sera were diluted 2-fold and four wells were used per dilution. 
Approximately 100 TCID50 of either the EC strain or Cooper strain were 
added to each well and the virus-serum mixture incubated at 37°C for one 
hour after which trypsinized MDBK cells (approximately 75000 cells/ well) 
were then added to each well. The plates were incubated at 37°C in 5% C02 
atmosphere for day 4 after which time the results were read. Titers were 
recorded as the reciprocal of the highest final serum dilution which 
completely protected at least 3 of the 4 wells from CPE. 
Preparation of Antigen for ELISA, 
Gel Electrophoresis and Western 
Blot. 
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MDBK cells grown in 150 cm2 flasks were infected with the EC and 
Cooper strains at a multiplicity of 1 as described earlier. One flask was not 
infected and served as uninfected control. When cells in the infected flasks 
showed 4+ CPE, cells in both infected and uninfected flasks were scraped 
and centrifuged at 1800 x g. Cell pellets were washed with PBS (phosphate 
buffer saline) andre-centrifuged. The pellets were then suspended in 20ml 
of PBS containing 0.5% Triton X-100 (Bio Rad) and 0.1% SDS. This 
mixture was sonicated and then stored at -70°C. These cells lysates were 
tested for protein concentrations by the Lowry method (Lowry et at., 1951). 
Protein concentrations of the lysates were equalized before they were used 
in ELISAs. 
For gel electrophoresis, MDBK cells in 15 cm2 wells were infected 
with 108 PFU of EC or Cooper strain in 1 ml of medium. After incubation 
at 37°C for 1 hour, the medium was replaced with MEM with 2% FCS and 
incubated for a further 4 hours. 35S-methionine and 14C-glucosamine were 
then added to final concentration of 2 uCi/ml and 1 uCi/ml, respectively, 
and the plates incubated overnight (Eberle and Courtney, 1980). At 24 
hours PI when the cells showed 4+ CPE, they were scraped, centrifuged at 
1800 x g and resuspended in water. 
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Immunoblot (Western Blot) antigen was prepared by infecting 150 
cm2 flasks of MDBK cells with the Cooper or EC strain as described above. 
When there was 4+ CPE, cells were scraped and centrifuged at 1500 x g for 
5 minutes. Pellets were washed with PBS, centrifuged and resuspended in 
600ul of water containing 0.5% TX-100 and 0.1% ofSDS. 
ELISA Procedure 
Infected and uninfected MDBK cells lysates were used as antigens 
for the ELISA. The assay was performed according to instructions provided . 
by Vector Laboratories for its Vecta Stain ABC kit (Vector Laboratories, 
CA). Round bottom 96-well polyvinyl plates were coated overnight at 4°C 
with celllysates diluted in 1 X Hanks' balanced salt solution containing 
0.375% sodium bicarbonate. Wells in one column of each plate were not 
coated with antigen and were used as blanks. After overnight incubation, 
wells were blocked with 1% bovine serum albumin (BSA) in 10% gelatin for 
one hour. Test sera plus standard positive and negative sera were diluted 
2-fold in 10% gelatin with 1% BSA before transfer to the wells. 50ul of 
different serum dilutions were added to wells containing the antigens. The 
plates were rocked for 1 hour at room temperature after which they were 
washed with PBST (0.5% Tween 20 in PBS). Then 50ul of 1:4000 
biotinylated rabbit anti-IgG were added to all wells except those used for 
blanks, plates rocked for an additional hour, washed again with PBST, after 
which 50ul of ABC reagent (made according to kit instructions) were added. 
After further incubation, wells were washed once more, and 100ul of 
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substrate solution (diaminobenzidine tetrahydrochloride in citrate buffer 
with 5ul of 30% H20 2 added as catalyst) was added to each well. After 30 
minutes incubation in dark, the reaction was stopped by adding 50ul of 2M 
H2S04• The absorbance of the solutions in each well were determined in a 
micro-ELISA plate reader using a wavelength mode of 490 nm. The final 
ELISA titer was read as the reciprocal of the highest serum dilution with 
an absorbance value on virus antigen which was at least 3 times 
higher than that on uninfected cell antigen. 
Gel Electrophoresis 
35S-methionine and 14C-glucosamine labelled celllysates were diluted 
1:2 in electrophoresis sample buffer (1 M urea, 2% SDS, 2% 
mercaptoethanol and 8% glycerol with tracking dye), heated at 100°C for 2 
minutes, and electrophoresed on 7% SDS-polyacrylamide gels as described 
by Laemmli (1970). Gels were run at constant current of 15-20 mAmp/gel 
in running buffer (0.1% SDS, 25 mM Tris and 192 mM glycine). When the 
dye band was about 1 em from the bottom of the plate, electrophoresis was 
stopped. The gels were fixed in destain (25% MEOH, 7% acetic acid) for 15 
minutes, and then transferred to Whatman paper. The gels were dried 
under vacuum with heat for 1-2 hours. The dried gels were put on Fuji X-




Antigens for the western blot were diluted in sample buffer and 
electrophoresis conducted in 7% SDS-PAGE as described above. Mter 
electrophoresis, the rest of procedur~s were adopted as described by Eberle 
and Mou, (1983). Mter electrophoresis, the gel was placed against a sheet 
of nitrocellulose and the proteins were electrophortically transferred from 
the gel onto the nitrocellulose paper (Burnette, 1981). The electroelution 
procedure was carried out in transfer buffer (20% methanol, 25 mM Tris 
and 192 mM glycine) at 1.50-2.00 Amps for 1-2 hours. 
Prior to addition of sera, nitrocellulose membranes with bound 
antigens were blocked with 2% BSA in lOX NT (NaCl 0.9%, Tris HCllO 
mM) for 1 hour at room temperature. Following this, test sera were allowed 
to react with the nitrocellulose bound antigens for 3 hours. Mter washing 5 
times with PBST, bound antibodies were detected by using 1125-labelled 
Staphylococcus protein A and autoradiography. Nitrocellulose membranes 
were dried and exposed to Fuji medical X-ray film (24.3cm x 25.4cm) for 12-
20 hours at room temperature. 
CHAPTER III 
RESULTS 
Clinical Signs Associated with Infection 
Rabbits Inoculated Ocularly 
In the first study, rabbits were inoculated with 107 PFU of either the 
Cooper or the EC strain on the scarified cornea. Cooper strain infected 
rabbits developed conjunctivitis on the second day following infection which 
lasted for at least a week. Mucopurulent conjunctivitis developed in a few 
animals. In rabbits infected ocularly with the EC-strain, conjunctivitis was 
much milder and was not observed beyond day 5 PI. ·overall, rabbits 
inoculated with the Cooper strain developed a more severe infection than 
those inoculated with the EC strain. A rabbit inoculated with EC strain 
developed convulsions on day 10 PI and was euthanized. None of the 
rabbits inoculated with the Cooper strain developed clinical encephalitis. 
Rabbits Inoculated Intranasally 
In the second study, rabbits were inoculated intranasally with 2xl07 
PFU of either the Cooper or EC strains. Most rabbits became depressed 
(hunched and hardly moved) on the second day after inoculation. 
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Depression was more severe in the rabbits inoculated with the Cooper 
strain and lasted for at least one week. Respiration rates increased in 
many rabbits, but particularly in those inoculated with the Cooper strain. 
Anorexia were also observed in some of the animals after inoculation. Only 
one rabbit inoculated with the EC strain developed fatal encephalitis on day 
7 PI. None of the rabbits inoculated with Cooper strain developed 
encephalitis. Again it was noted that rabbits inoculated with the Cooper 
strain were more severely affected clinically following intranasal 
inoculation. 
Immune Response to Infection 
First Study 
In the first study, 36 rabbits were infected (18 with each virus strain) 
and 4 animals sacrified on days 1, 3, 5, 8, 11 and 14 PI. Sera were obtained 
at the time of sacrifice. These sera were tested for neutralizing antibodies 
and for the presence of IgG antibodies to BHV-1 by ELISA. 
Serum neutralizing antibodies were first detected on day 14 PI, and 
only in rabbits inoculated with the Cooper strain virus. None of the rabbits 
inoculated with the EC strain seroconverted by day 14 PI in first study. 
The seropositive sera were obtained from both rabbits sacrificed on day 14 
PI, and titers of 1:8 and 1:16 were recorded (Table I). 
When sera were tested for the presence of antiviral IgG by ELISA, 
antibodies were detected as early as 8 days PI in both groups of rabbits 
TABLE I 
VIRUS NEUTRALIZING AND ELISA ANTIBODY TITERS IN SERA OF RABBITS 
INOCULATED OCULARLY WITH THE COOPER STRAIN VIRUS 
ELISA Ab titers against 
Animal Postinoculation Neutralizing 
Number days Ab titers Cooper EC-strain 
1 1 o• ob 0 
2 1 0 0 0 
4 3 0 0 0 
6 3 0 0 0 
7 5 0 0 0 
8 5 0 0 0 
10 8 0 800 100 
11 8 0 400 50 
13 11 0 1600 100 
14 11 0 1600 50 
16 14 8 6400 800 
17 14 16 12800 1600 
a For neutralizing antibody titers, 0 = <4 
b For ELISA antibody titers, 0 = <25 
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(Tables I and II). In rabbits inoculated with the Cooper strain, an average 
titer of 600 was recorded on day 8 PI and this increased to 9600 by day 14 
PI. In rabbits inoculated with the EC strain, antibodies were detected in 
only one of the two serum samples tested on both day 8 and day 11 PI. 
Rabbit #34, which was to be sacrificed on day 14 PI, died of encephalitis on 
day 10. It had, at this time, detectable amounts of antibodies in its serum. 
When the sera from rabbits inoculated with the Cooper strain were 
tested against the EC strain and the Cooper strain antigen by ELISA, 
antibody titers in individual rabbits were at least 8-fold higher on the 
homologous Cooper than with the heterologous EC strain antigens (Table D. 
However, when sera from the rabbits inoculated with the EC strain were 
similarly tested, titers were almost the same irrespective of the antigens 
used (Table II). 
Second Study 
In the second study, sera from rabbits were obtained on day 21 PI, 
except for the one sample collected on day 7 PI from the rabbit that 
developed fatal encephalitis. Serum neutralizing antibody titers and lgG 
antibody titers were determined for all these sera, and results are given in 
the Table III. Of the 4 rabbits inoculated with EC strain, only two 
seroconverted by day 21 Pl. One of the rabbits that did not seroconvert 
died on day 7 PI. All 3 rabbits inoculated with the Cooper strain 
seroconverted by 21 day PI with NA titers ranging from 1:16 - 1:32. 
TABLE II 
VIRUS NEUTRALIZING AND ELISA ANTIBODY TITERS IN SERA OF RABBITS 
INOCULATED OCULARLY WITH THE EC-STRAIN VIRUS 
ELISA Ab titers against 
Animal Postinoculation Neutralizing 
Number days Ab titers Cooper EC-strain 
19 1 o• ob 0 
20 1 0 0 0 
22 3 0 0 0 
24 3 0 0 0 
25 5 0 0 0 
26 5 0 0 0 
28 8 0 0 0 
29 8 0 200 200 
34c 10 0 400 800 
31 11 0 0 0 
32 11 0 400 400 
36 14 0 400 400 
a For neutralizing antibody titers, 0 = <4 
b For ELISA antibody titers, 0 = <25 
c Rabbit died of encephalitis on day 10 PI 
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Neutralizing titers in two of those rabbits were 4-fold lower when the 
heterologous EC strain was used as the test virus (Table Ill). Similarly, NA 
titers in sera from rabbits inoculated with the EC strain tended to be higher 
when the homologous virus was used as the test virus. This indicated that 
virus neutralizing antibodies in recovered rabbits differed in their ability to 
neutralize the two virus strains. 
When the sera from rabbits in the second study were tested for 
presence of IgG antibodies by ELISA, the rabbits inoculated with the Cooper 
strain had, on average, higher serum antibody titers then rabbits inoculated 
with EC strain (Table III). However, all these sera were tested only against 
the Cooper antigen. 
Hyperimmune sera obtained in the third study were also tested by 
VN test. The BHV-1 Cooper strain hyperimmune serum had a neutralizing 
antibody titer of 1:256 when tested with the Cooper strain, but the titer was 
4-fold lower against the EC strain. The EC strain hyperimmune serum had 
a titer of 1:64 when tested against the EC strain but had a titer of 1:16 
when tested with the Cooper strain. These results indicate once more, that 
the neutralizing capacity of sera from hyperimmunized rabbits were 
different for the two strains. 
Analysis of Viral Proteins 
Since the VN tests and ELISA assays suggested that the two viruses 
differed antigenically, a comparison of their protein profiles was performed. 
TABLE III 
VIRUS NEUTRALIZING AND ELISA ANTIBODY TITERS IN SERA OF RABBITS 
INOCULATED INTRANASALLYWITH THE EC- OR COOPER STRAINS 
NA titersa when tested against 
Animal Inoculated ELISA 
Number with: Ab titersb Cooper 
7 EC 51200 
8 EC oc 
9 EC 25600 
1o• EC 0 
11 Cooper 51200 
12 Cooper 51200 
13 Cooper 102400 
14 Contro.l 0 
a All sera (except for animal #10) were obtained 21 days PI 
b ELISA performed using Cooper strain viral antigen 
c For ELISA antibody titers, 0 = <25 
d For neutralizing antibody titers, 0 = <4 




















Cells infected with the Cooper strain, cells infected with the EC strain and 
uninfected MDBK cells were labelled metabolically with 358-methionine. 
When the radio-labelled proteins were separated by SDS-PAGE, 
autoradiography revealed very similar polypeptide patterns for both viruses 
as can be seen in Figure 1. Thirty MDBK cell proteins were identified. 
Approximately 21 virus-specific protein bands were detected for the Cooper 
strain and 20 virus-specific bands for the EC strain. Although there is a lot 
of similarity between the two strains, several differences between the EC 
strain and the Cooper strain can be seen. These differences are in proteins · 
# p9, p12 and p17. 
Since it has been established that immune response to BHV-1 is 
mediated predominantly against the viral glycoproteins, MDBK cells 
infected with the EC strain and the Cooper strain were metabolically 
labelled at 4 hours PI with 14C-glucosamine. Proteins were separated by the 
SDS-PAGE and autoradiography revealed several different glycoprotein 
bands in the infected cells. The glycoprotein bands corresponded to specific 
viral polypeptides. In addition to minor differences in the glycoprotein 
bands (Figure 1), a major difference appeared to exist in the region of gp 10. 
This gp 10 corresponds to the gill glycoprotein in the case of the Cooper 
strain. 
These results indicate that the EC strain protein profile, especially 
its glycoproteins, are different from the Cooper strain and that one of these 
differences is in the gill region. 
Figure 1: SDS-PAGE analysis ofBHV-1 Cooper and EC glycoproteins 
and polypeptides. Uninfected MDBK cells (Lanes 1, 6) 
and MDBK cells infected with BHV-1 Cooper (Lanes 2, 5) 
or EC (Lanes 3, 4) were labelled with 14C-glucosamine 
(Lanes 1-3) or 358-methionine (Lanes 4-6). Polypeptides 
were separated by SDS- PAGE on 7% gels. Viral proteins 
are numbered in lane 4. The polypeptides differing 
between the Cooper and EC are indicated with an arrowhead. 
Molecular weight of certain major polypeptides are shown 
at right. 















In order to determine which viral polypeptides were recognized by 
antibodies in the sera of infected rabbits, viral proteins were separated by 
SDS-PAGE, transferred to a nitrocellulose membrane and reacted with sera 
by western blotting. Sera from rabbits inoculated with the EC strain did 
not bind to any viral antigens. Only one serum sample from a rabbit 
inoculated with the Cooper strain (collected day 14 PI) reacted with the 
Cooper virus antigens. This serum recognized two lower molecular weight 
proteins of 50 K and 39 K daltons. 
Since most of the above mentioned sera did not react by western 
blotting, hyperimmune sera which contained higher titers of antiviral 
antibodies were used for the next stage of the study. The hyperimmune 
sera were reacted to viral proteins separated by SDS-PAGE and results 
showed different reactivity patterns for the two viruses (Figure 2). In Lane 
4, it can be observed that the anti-EC hyperimmune serum recognized 
several differents EC strain ·protein bands with very intense reactivity with 
the 91 K protein. Anti-EC strain hyperimmune serum also reacted with 
the Cooper antigen but recognized fewer different protein (lane 5). In lane 
6 containing uninfected MDBK cells protein, no reactivity with anti-EC 
hyperimmune sera was observed. 
Figure 2 also shows anti-Cooper hyperimmune sera reacted with 
uninfected MDBK cell, Cooper strain and EC strain antigens. As can be 
seen, the sera reacted with a few polypeptides of the Cooper strain only and 
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there is intensive reactivity in the gill glycoprotein region. When EC 
strain, Cooper strian and uninfected cells were treated with normal rabbits 
serum (Figure 3, Lanes 4-6), no reactivity was observed. 
Because the anti-Cooper serum did not recognize the glycoproteins of 
the EC strain virus, and because there appeared to be differences in the 
glycoproteins of the two viruses when 14C-glucosamine labelled infected cells 
proteins were examined, polyclonal hyperimmune antisera raised to the 
purified gland gill glycoproteins ofBHV-1 (Cooper) were tested against the 
Cooper strain, the EC strain antigens and uninfected MDBK cells by 
western blot. The gl and gill sera recognized only Cooper strain antigens . 
The gl anti serum reacted with gl glycoprotein and similarly gill anti 
serum recognized only gill glycoprotein (Figure 3). 
These results indicated that anti-Cooper serum, and anti gland gill 
sera recognized only Cooper strain antigens; they did not react with EC 
strain antigens. Looking at these western blots, it appears that the Cooper 
strain is antigenically different from the EC strain. This difference is 
particularly evident in the gill glycoprotein. 
Figure 2: Immunogenicity of BHV-1 (Cooper) and BHV-1 (EC) 
polypeptides. Proteins of uninfected MDBK cells 
(Lanes 1, 6), MDBK cells infected with BHV-1 Cooper 
(Lanes 2, 5), or EC (Lanes 3, 4) were separated by 
SDS-PAGE and transferred to a nitrocellulose membrane 
for western blot analysis. The membranes were reacted 
with hyperimmune rabbit anti-BHVl Cooper serum 
(Lanes 1-3) or hyperimmune rabbit anti-BHVl EC 
serum (lanes 4-6). The position of the Cooper giii 
glycoprotein is indicated at left. 
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Figure. 3: Reactivity of antisera to BHV1 Cooper gl and gill 
glycoproteins with the Cooper and EC glycoproteins. 
Proteins of uninfected MDBK cells (Lanes 1, 4, 7), 
MDBK cells infected with BHV-1 Cooper (Lanes 2, 5, 8) 
or EC (Lanes 3, 6, 9) were separated by SDS-PAGE 
and transferred to a nitrocellulose membrane for 
western bolt analysis. The membranes were reacted 
with rabbit anti-BHV1 Cooper gl serum (Lanes 1-3) 
nonimmune rabbit serum (lanes 4-6), or rabbit 
anti-BHV1 Cooper gill serum. The position of 
the gl glycoprotein is indicated at left and 
of gill at right. · 
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CHAPTER IV 
DISCUSSION 
Two strains of BHV-1 were used in this study: the respiratory Cooper 
strain (York, 1957) and the neurovirulent EC strain of BHV-1 originally 
isolated by Eugster et al., (1974) in Texas. Preliminary work in our 
laboratory indicated that the RE migration pattern of the EC strain was 
very similar to the RE patterns reported for two other neurovirulent strains, 
the N-569 strain isolated in Australia by French (1962) and the A-663 
Arge~tine isolate reported by Carrillo et al., (1983). TheRE migation 
patterns of these isolates have been published (Brake and Studdert, 1985; 
Engels et al., 1986/87). The neurovirulent N-569 strain is antigenically 
different from the respiratory IBR virus ( Bagust, 1972) and has been 
shown to cause fatal encephalitis in calves when inoculated intranasally. 
The purpose of the present study was to compare the pathogenesis of our 
neurovirulent EC strain to the Cooper strain in rabbits, and to determine if 
the two strains were antigenically different. 
Only the neurovirulent EC strain caused encephalitis in rabbits in 
the present study. Of the rabbits inoculated ocularly on the scarified cornea 
with 107 PFU of the EC strain virus, one rabbit had to be euthanized on day 
10 PI when it suddenly developed convulsions. In those inoculated 
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intranasally with 107 PFU of the same virus, one (25%) developed clinical 
encephalitis on day 7 PI. Rabbits inoculated similarly with the same dose 
of the respiratory Cooper virus did not develop clinical encephalitis. This 
confirms previous observations made in our laboratory regarding the 
neuropathogenicity of the EC strain for rabbits. In these studies 25%-75% 
of rabbits inoculated ocularly with the virus developed clinical encephalitis 
10-14 days PI; in the present study; only 1 out of 18 rabbits inoculated 
ocularly with the EC virus developed fatal encephalitis. This was partly 
because rabbits were sacrificed on various days PI and so did not survive to 
develop fatal encephalitis between 10-14 days PI. 
Meningoencephalitis caused by BHV-1 occurs sporadically in cattle. 
An outbreak of encephalitis in calves caused by BHV-1 was first reported in 
the USA by Barenfus et al., in (1963). Another ourbreak, reported by 
Eugster et al (1974) occured in Texas range calves. However, the virus 
isolated from the central nervous system of calves during these outbreaks 
were not compared by RE migratin pattern and were identified as IBR 
virus. As mentioned, our laboratoy confirmed that the virus isolated by 
Eugster et al (1974) was indeed a BHV-1 virus with aRE migration pattern 
resembling those of the two other well characterized neurovirulent strains 
N-569 and A-663, referred to as BHV-1.3 (Metzler et al., 1986) or bovine 
encephalitis herpesvirus (Studdert, 1989). When the Austalian N-569 
isolate was inoculated intranasally or intravaginally in cattle, calves 
developed clinical meningoencephalitis between days 10 and 14 PI (Hallet 
al., 1966; Bagust, 1972). It is interesting to note that both rabbits and 
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calves tend to develop clinical encephalitis within the same time frame after 
virus inoculation. 
Kelly (1977) infected rabbits with IBR virus and reported that they 
developed conjunctivitis post inoculation. Similarly, Lupton et al., (1979) 
observed conjunctivitis in rabbits on the second day after inoculation with 
IBR virus. In our studies we noticed moderately severe conjunctivitis in 
rabbits inoculated with the Cooper strain starting on the second day PI. On 
the other hand, although rabbits inoculated with the EC strain also 
developed conjunctivitis, it was noticeably much milder. We also noticed 
clinical disease in some rabbits inoculated with the viruses intranasally, 
including depression, anorexia and some accelerated respiratory rates. 
However, none of the animals died as a result of respiratory complications, 
and rabbits inoculated with the Cooper strain virus were again more 
severely affected clinically. 
The level of immune response to IBR virus varies with the route of 
infection. Bagust (1972) noted that serum NA antibody titers were highest 
when calves were inoculated by the conjunctival route and was intermediate 
after intranasal inoculation. Maximum IgG antibody titers occurred on day 
35 PI when cattle were inoculated by the intranasal route (Guy and 
Potgieter, 1985). In our rabbits inoculated intranasally, serum NA titers 
were observed in all rabbits (n=3) inoculated with the Cooper virus, but in 
only 2 out of 3 rabbits inoculated with the EC strain. In rabbits inoculated 
ocularly, only those inoculated with the Cooper strain seroconverted by day 
14 PI; antibodies were not measured after this time. Rabbit IgG antibodies 
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specific for BHV-1 were detected by ELISA as early as 8 days PI in rabbits 
inoculated ocularly and increased until day 14 PI at which time titers were 
8-fold higher in sera of rabbits inoculated with the Cooper strain. The 
ELISA is a highly sensitive method for detecting presence of antibodies in 
serum of calves (Edward and Goita, 1987) and Collins et al., (1984/85) 
detected antibody as early as day 8 PI in sera of BHV-1 infected calves. It 
appears, therefore, that rabbits inoculated with BHV-1 will develop a good 
humoral immune response postinoculation, and that rabbits inoculated with 
the Cooper strain tended to respond earlier with slightly higher serum NA 
titers and significanly higher ELISA titers than did rabbits inoculated with 
the EC strain. 
The virus neutralization test is a sensitive test for measuring 
neutralizing antibody titers in sera (Carbey et al., 1972). Using the virus 
neutralization test, various researchers have failed to detect antigenic 
differences between the respiratory (IBR) and the genital (IPV) strains of 
BHV-1 (Bowling et al., 1969; House et al., 1971). In fact Gregersene et al., 
(1985) indicated that the antigenic separation of IBR from IPV by 
neutralization with rabbit hyperimmune sera was not possible. Bagust 
(1972) detected no antigenic differences between IBR and IPV by 
neutralization kinetic assays, but he mentioned that the antigenic nature of 
the neurovirulent N-569 virus was significantly different from IBR virus by 
neutralizing kinetics. Also, Freidli et al., (1987) reported that monoclonal 
antibodies directed against BHV-1.1 only partially reacted with BHV-1.3 
isolates, indicating that antigenic differences exist between these strains. 
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In the present study, sera from hyperimmunized rabbits and sera 
from rabbits inoculated intranasally with either the Cooper or EC strains 
neutralized both virus strains. In most instances, however, higher levels of 
rabbit anti-Cooper sera were required to neutralize the same quantity of EC 
as Cooper virus in the neutralization test. The same was true of serum 
from one EC strain innoculated rabbit, where 8-fold higher concentration of 
sera was needed to neutralize the same quantity of Cooper as EC strain. 
This would indicate that although the viruses are related antigenically, 
strain-specific antiserum could differentiate between the two BHV-1 strains. 
by the virus neutralization test in this study. The antigenic difference 
between the two strains was underscored by the fact that antibodies in sera 
of rabbits inoculated ocularly with the Cooper strain had significantly 
higher titers when mearured against its homologous antigen by ELISA than 
against the heterologous the EC strain antigen. 
·The findings that virus-specific antibodies bound differently to the 
two viruses prompted us to analyse and compare the viral polypeptides of 
the two strains and to determine antigenic differences. Autoradiography of 
SDS-PAGE separated viral proteins revealed that the Cooper strain had 21 
proteins whereas the EC strains had 20 proteins. It is impossible to 
compare exactly our results to those published by others, since detection 
procedures and percentage gels used varied. However, the number and 
molecular weight range of proteins in our study are in general agreement 
with those reported by others (Misra et al., 1982; Trepanier et al., 1986; 
Metzler et al., 1985, 1986). The migrational pattern are obviously similar 
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but display certain differences which distinquish BHV-1.1 Cooper from the 
BHV-1.3 3 EC strain (Meztler et al., 1986). The 14C-glucosamine labelled 
proteins showed a big difference between strains in the region of gp10. The 
Cooper gill glycoprotein is located in this region (van Drunen littel-van den 
Hurk et al., 1986) and appears to be more glycosylated in the Cooper than 
in the EC strain. 
Carbohydrate moieties of viral glycoproteins can have a strong 
influence on functional as well as antigenic and immunogenic activities 
(Alexandar et al., 1984). Deglycosylated glycoproteins induce significantly 
lower antibody responses in rabbits than do native glycoproteins, and 
antibodies raised against the deglycosylated glycoproteins have much lower 
neutralizing titers (van Drunen Littel van den Hurk et al., 1990). This 
suggests that the immunogenicity of several epitopes on gill may be 
carbohydrate depended. If the Cooper strain glycoprotein is more 
glycosylated (Figure 1), it may explaine why the Cooper strain was more 
immunogenic in the rabbit. 
In our first Western blot experiments, in which we tested sera from 
ocularly inoculated rabbits, only the serum of one Cooper inoculated rabbit 
collected on day 14 PI bound to some lower molecular weight Cooper virus 
protiens. These proteins appeared to be in the region of internal capsid 
proteins. Eberle et al., (1985) using western blots noticed that early in 
primary infections, antibodies were directed against an internal capsid 
protein of HSV. 
Studies with monoclonal antibodies have identified and recognized 
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two neutralizing epitopes on glycoproteins gill (91 K mol wt) and gl (74 K 
mol wt) (van Drunen Littel-vanden Hurk et al., 1985). Trudel et al., (1987) 
also identified the 90 K mol wt glycoprotein (gill) as a major immunogenic 
protein. Gregerson et al., (1985) identified two major glycoproteins [93 K 
(gill) and 7 4 K (gl) mol wt] that induced neutralizing antibodies and 
Tropanier et al., (1986) also identified the 90 K mol wt glycoprotein (gill) as 
an important neutralizing epitope. · 
By reacting hyperimmune sera to viral proteins in western blots, we 
found that a glycoprotein in the range of mol wt 90 K was a major antigenic 
protein. Rabbit anti-EC hyperimmune serum recognized this glycoprotein 
in the EC strain virus by western blotting, but did not recognize the related 
Cooper virus glycoprotein as intensely. When rabbit anti-Cooper gill 
antiserum was tested, it recognized a protein band only in the Cooper virus; 
this protein band was located in the region of gill glycoprotein (Figures 2 
and 3). It appears, therefore, that the gill glycoprotein of the Cooper and 
neurovirulent EC strain are antigenically different. 
In conclusion, it appears that the neurovirulent BHV-1 EC strain is 
different from the respiratory Cooper strain both antigenically and in ability 
to cause clinical disease and fatal encephalitis in rabbits. It would be 
interesting to find out what role, if any, the antigenically different viral 
glycoprotein gill plays in determining BHV -1 neurovirulence. 
CHAPTERV 
SUMMARY AND CONCLUSIONS 
The purpose of these studies was to examine the humoral immune 
response of rabbits to infection with two different BHV-1 strains - a 
respiratory (Cooper) strain and a neurovirulent (EC) strain- and to 
determine if the two strains were antigenically different. 
For this purpose, rabbits were inoculated with the two virus strains 
intranasally and ocularly. Ocularly infected rabbits developed conjuctivitis, 
whereas some intranasally infected animals became depressed, anorexic and 
developed increased respiratory rates. Rabbits inoculated with the Cooper 
strain tended to be more severely affected clinically. Two rabbits inoculated 
with the EC strain developed fatal encephalitis, one on day 7 and the other 
on day 10 PI. None of the rabbits inoculated with the Cooper strain died as 
a result of the infection. 
Only rabbits inoculated ocularly with the Cooper strain developed 
detectable amounts of serum neutralizing antibodies by day 14 PI. In 
rabbits inoculated intranasally, 100% of those inoculated with the Cooper 
strain seroconverted by day 21 PI, whereas only 66% of those inoculated 
with the EC strain seroconverted by that time. Serum ELISA antibody 
titers were noted on day 8 PI in both groups of rabbits, and these titers 
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increased to day 14 PI. Titers in the Cooper virus inoculated rabbits tended 
to be higher at all times PI. 
Serum virus neutralization tests indicated that antibodies in sera of 
rabbits inoculated with a particular strain of virus were better able to 
neutralize the homologous virus than the heterologous virus. Also, 
antibodies in sera of rabbits inoculated with the Cooper virus tended to bind 
to Cooper virus antigen to a significantly higher degree than the EC. This 
indicated that the different strains are antigenically distinct. 
Viral protein profiles could distinguish between the two strains, 
although the differences were slight. The Cooper strain glycoproteins 
tended to be more glycosylated, especially in the region of the gill 
glycoprotein. A big difference could be detected in this gill region between 
the Cooper and EC strain glycoproteins. 
Anti-EC hyperimmune serum recognized several proteins in both 
Cooper and EC strains by Western immunoblots. The anti-Cooper strain 
serum, however, recognized only Cooper strain proteins and showed intense 
activity in the gill region. Anti-Cooper gill sera, and to a much lesser 
extent anti -gl sera, reacted strongly to the Cooper virus glycoproteins, but 
not to any of the EC strain virus proteins by immunoblot. 
It appears, therefore, that these two BHV-1 strains are antigenically 
distinct and differ in their ability to cause clinical disease in rabbits. Only 
the EC strain virus causes fatal encephalitis in rabbits, but the Cooper 
strain appears to be more immunogenic following inoculation. The gill 
glycoprotein at least, can clearly differentiate the two strains antigenically. 
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